EUVIMEDEUVIMED entdecken
Multizentrische Studie

Usefulness of genotyping APC gene for individualizing management of patients with familial adenomatous polyposis

Yoshiko Mori, Hideyuki Ishida, Noriyasu Chika, Tetsuya Ito, Kunihiko Amano, Kenichi Chikatani, Yoji Takeuchi, Mitsuhiro Kono, Satoki Shichijo, Akiko Chino, Toshiya Nagasaki, Akinari Takao und 8 weitere

International Journal of Clinical Oncology · 2023

DOI: 10.1007/s10147-023-02419-6 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Clinical Oncology, 2023. Verfasst von Yoshiko Mori und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama, 350-8550, Japan. Hauptthemen laut MEDLINE: Genes, APC, Adenomatous Polyposis Coli. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Colorectal polyp burden is crucial for the management of patients with familial adenomatous polyposis (FAP). However, accurate evaluation of polyp burden is difficult to standardize. This study aimed to examine the possible utility of genotype-oriented management of colorectal neoplasms in patients with FAP. METHODS: Clinicopathological data from genetically proven patients with FAP was analyzed using the database of a nationwide retrospective Japanese multicenter study. The cumulative incidence of CRC was evaluated between different genotype groups. Genotype-1 were defined as germline variants on attenuated FAP-associated regions (codons 1-177, alternative splice site of exon 10 (codon 312), 1581-2843) and Genotype-2 as the other variants. Weibull and Joinpoint analyses were performed to determine the annual percentage changes in CRC risk. RESULTS: Overall, 69 men and 102 women were included. Forty-eight patients underwent colorectal resection for the first CRC, and five patients underwent resection for first cancer in the remnant anorectal segment after prophylactic surgery. The 70-year cumulative incidence of CRC in all patients was 59.3%. Patients with Genotype-1 (n = 23) demonstrated a lower risk of CRC stages II-IV than those with Genotype-2 (n = 148, P = 0.04). The risk of stage II-IV CRC was estimated to increase markedly at the age of 49 years in the Genotype-1 patients and 34 years in the Genotype-2 patients, respectively. CONCLUSIONS: Different interventional strategies based on genotypes may be proposed for the clinical management of patients with FAP. This policy needs to be validated in further prospective studies focusing on long-term endoscopic intervention and optimal age at prophylactic (procto)colectomy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genes, APCAdenomatous Polyposis ColiMaleHumansFemaleMiddle AgedGenotypeProspective StudiesRetrospective Studies

Stichwörter der Autor:innen

Adenomatous polyposis coli geneColorectal cancerFamilial adenomatous polyposisGenotype

Autor:innen und Institutionen

  • Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama, 350-8550, Japan.
  • The Committee of Hereditary Colorectal Cancer, Japanese Society for Cancer of the Colon and Rectum, Tokyo, Japan.
  • Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Department of Gastroenterology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Department of Gastroenterology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.

Zitieren

APA

Mori, Y., Ishida, H., Chika, N., Ito, T., Amano, K., Chikatani, K., Takeuchi, Y., Kono, M., Shichijo, S., Chino, A., Nagasaki, T., Takao, A., Takao, M., Nakamori, S., Sasaki, K., Akagi, K., Yamaguchi, T., Tanakaya, K., Naohiro, T., & Ajioka, Y. (2023). Usefulness of genotyping APC gene for individualizing management of patients with familial adenomatous polyposis. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-023-02419-6

Vancouver

Mori Y, Ishida H, Chika N, Ito T, Amano K, Chikatani K, et al. Usefulness of genotyping APC gene for individualizing management of patients with familial adenomatous polyposis. International Journal of Clinical Oncology. 2023. doi:10.1007/s10147-023-02419-6

BibTeX
@article{Mori2023,
  author = {Mori, Yoshiko and Ishida, Hideyuki and Chika, Noriyasu and Ito, Tetsuya and Amano, Kunihiko and Chikatani, Kenichi and Takeuchi, Yoji and Kono, Mitsuhiro and Shichijo, Satoki and Chino, Akiko and Nagasaki, Toshiya and Takao, Akinari and Takao, Misato and Nakamori, Sakiko and Sasaki, Kazuhito and Akagi, Kiwamu and Yamaguchi, Tatsuro and Tanakaya, Kohji and Naohiro, Tomita and Ajioka, Yoichi},
  title = {Usefulness of genotyping APC gene for individualizing management of patients with familial adenomatous polyposis},
  journal = {International Journal of Clinical Oncology},
  year = {2023},
  doi = {10.1007/s10147-023-02419-6}
}
Kostenlos starten →